Shannon L. Maude, MD, PhD, highlighted promising long-term disease-free survival and MRD negativity with tisagenleucel in ...
Melanocyte melanin synthesis creates constitutive ROS vulnerability, and impaired Nrf2-mediated antioxidant responses enable ...
Forging multistakeholder partnerships and prioritizing high-impact specialities can help convert market volatility to an advantage. An aging population, growing chronic disease burden, and higher ...
Treatment Selection and Eligibility in Follicular Lymphoma,' Ryan Haumschild, PharmD, MS, MBA, CPEL led the conversation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results